High-risk HPV infection after five years in a population-based cohort of Chilean women

Infectious Agents and Cancer

Volumn 6, Issue 1, 2011, Pages

  Ferreccio, Catterina ^a   Van De Wyngard, Vanessa ^a   Olcay, Fabiola ^b   Domínguez, M Angélica ^a   Puschel, Klaus ^a   Corvalán, Alejandro H ^a   Franceschi, Silvia ^c   Snijders, Peter J F ^d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Centro de Formacion Tecnica Santo Tomas   (Chile)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILE; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; GENOTYPE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 81055148322     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-6-21     Document Type: Article

References (19)

1. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Ferreccio C, Prado R, Luzoro A, Ampuero SL, Snijders PJF, Meijer CJLM, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM, Cancer Epidemiol Biomarkers Prev 2004 13 12 2271 6 15598792 (Pubitemid 40054329)
2. Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. Ferreccio C, Corvalán A, Margozzini P, Viviani P, González C, Aguilera X, Gravitt PE, BMC Public Health 2008 8 78 10.1186/1471-2458-8-78 18304362 (Pubitemid 351520296)
3. Departmento de Estadísticas e Informacián de Salud, Ministerio de Salud, Chile. http://deis.minsal.cl/vitales/Mortalidad-causa/ Chile.htm last accessed August 24 2011
4. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Jacobs MV, Walboomers JMM, Snijders PJF, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ, Int J Cancer 2000 87 221 7 10.1002/1097- 0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2 10861478 (Pubitemid 30434349)
5. Comportamientos sexuales y diferencias de género en adolescentes usuarios de un sistema público de salud universitario. González E, Molina T, Montero A, Martínez V, Leyton C, Rev Méd Chile 2007 135 10 1261 1269 21267112
6. Natural history of anogenital human papillomavirus infection and neoplasia. Schiffman M, Kjaer SK, J Natl Cancer Inst Monogr Oxford University Press 2003 31 14 9 12807940
7. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Castellsagué X, Schneider A, Kaufmann AM, Bosch FX, Gynecol Oncol 2009 115 3 Suppl 15 23 19819540
8. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodríguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD, J Infect Dis 2005 191 1808 16 10.1086/428779 15871112 (Pubitemid 40705386)
9. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD, J Natl Cancer Inst 2010 102 315 324 10.1093/jnci/djq001 20157096
10. Nuevos paradigmas y desafíos en la prevencián y control del cáncer de cuello uterino en América Latina. Almonte M, Murillo R, Sánchez GI, Jeránimo J, Salmerán J, Ferreccio C, Lazcano-Ponce E, Herrero R, Salud Publica Mex 2010 52 544 559 10.1590/S0036-36342010000600010 21271014
11. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines. Almonte M, Sasieni P, Cuzick J, Best Pract Res Cl Ob 2011 25 5 617 629 10.1016/j.bpobgyn.2011.05.003
12. Natural history of infections with high-risk HPV in Chinese women with abnormal cervical cytology findings at baseline. Guo YL, You K, Qiao J, Zhao YM, Liu CR, Geng L, Int J Gynecol Obstet 2010 110 137 140 10.1016/j.ijgo.2010.03. 021
13. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS, Am J Epidemiol 2008 168 2 123 137 10.1093/aje/kwn036 18483125 (Pubitemid 351951589)
14. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. Kjaer SK, Frederiksen K, Munk C, Iftner T, J Natl Cancer Inst 2010 102 19 1478 1488 10.1093/jnci/djq356 20841605
15. Prospective study of human papillomavirus types, HPV persistence, and risk of squamous cell carcinoma of the cervix. Sundström K, Eloranta S, Sparén P, Dahlström LA, Gunnell A, Lindgren A, Palmgren J, Ploner A, Sanjeevi CB, Melbye M, Dillner J, Adami HO, Ylitalo N, Cancer Epidemiol Biomarkers Prev 2010 19 10 2469 78 10.1158/1055-9965.EPI-10-0424 20671136
16. Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Québec, Canada. Vijayaraghavan A, Efrusy MB, Mayrand MH, Santas CC, Goggin P, Can J Public Health 2010 101 3 220 5 20737813
17. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernández M, Granados-García V, Pérez R, Salmerán J, Cancer Causes Control 2011 22 2 261 72 10.1007/s10552-010- 9694-3 21170578
18. Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa. Vijayaraghavan A, Efrusy M, Lindeque G, Dreyer G, Santas C, Gynecol Oncol 2009 112 2 377 83 10.1016/j.ygyno.2008.08.030 19081611
19. The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies. Holmes J, Hemmett L, Garfield S, Eur J Health Econ 2005 6 1 30 7 10.1007/s10198-004-0254-1 15682286 (Pubitemid 40543268)